Veradigm Inc. (MDRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Veradigm Inc. (MDRX) has a cash flow conversion efficiency ratio of 0.024x as of September 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.14 Million) by net assets ($1.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Veradigm Inc. (MDRX) total market value for the company's overall valuation and market capitalisation.
Veradigm Inc. - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Veradigm Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Veradigm Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Veradigm Inc. ranked by their cash flow conversion efficiency. Explore MDRX operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UPC Technology Corp
TW:1313
|
-0.018x |
|
Italtile Ltd
JSE:ITE
|
0.137x |
|
London Stock Exchange Group PLC
LSE:LSEG
|
0.064x |
|
Chongqing Yukaifa Co Ltd
SHE:000514
|
0.003x |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
0.056x |
|
Guangdong Brandmax Marketing Co Ltd
SHE:300805
|
0.016x |
|
Meorient
SHE:300795
|
0.027x |
|
Pansoft Company Limited
SHE:300996
|
N/A |
Annual Cash Flow Conversion Efficiency for Veradigm Inc. (1998–2024)
The table below shows the annual cash flow conversion efficiency of Veradigm Inc. from 1998 to 2024. View MDRX share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.02 Billion | $115.56 Million | 0.114x | 0.00% |
| 2022-12-31 | $1.02 Billion | $115.56 Million | 0.114x | +312.03% |
| 2021-12-31 | $1.41 Billion | $-75.43 Million | -0.054x | +16.36% |
| 2020-12-31 | $1.67 Billion | $-106.72 Million | -0.064x | -277.95% |
| 2019-12-31 | $1.29 Billion | $46.25 Million | 0.036x | -16.23% |
| 2018-12-31 | $1.58 Billion | $67.90 Million | 0.043x | -75.53% |
| 2017-12-31 | $1.59 Billion | $279.42 Million | 0.176x | +8.39% |
| 2016-12-31 | $1.66 Billion | $269.00 Million | 0.162x | +8.62% |
| 2015-12-31 | $1.42 Billion | $211.58 Million | 0.149x | +85.01% |
| 2014-12-31 | $1.28 Billion | $103.50 Million | 0.081x | +31.16% |
| 2013-12-31 | $1.32 Billion | $80.99 Million | 0.061x | -64.56% |
| 2012-12-31 | $1.28 Billion | $222.67 Million | 0.173x | -4.74% |
| 2011-12-31 | $1.48 Billion | $268.75 Million | 0.182x | +80.01% |
| 2010-12-31 | $1.38 Billion | $139.90 Million | 0.101x | -49.39% |
| 2009-12-31 | $700.40 Million | $139.92 Million | 0.200x | +287.81% |
| 2008-12-31 | $700.37 Million | $36.08 Million | 0.052x | 0.00% |
| 2007-12-31 | $700.37 Million | $36.08 Million | 0.052x | -40.57% |
| 2006-12-31 | $316.25 Million | $27.41 Million | 0.087x | -48.32% |
| 2005-12-31 | $98.42 Million | $16.51 Million | 0.168x | +6.04% |
| 2004-12-31 | $78.69 Million | $12.45 Million | 0.158x | +153.41% |
| 2003-12-31 | $83.39 Million | $5.21 Million | 0.062x | +149.74% |
| 2002-12-31 | $85.82 Million | $-10.77 Million | -0.125x | +62.45% |
| 2001-12-31 | $98.63 Million | $-32.96 Million | -0.334x | -289.26% |
| 2000-12-31 | $290.98 Million | $-24.98 Million | -0.086x | +54.44% |
| 1999-12-31 | $67.40 Million | $-12.70 Million | -0.188x | +74.43% |
| 1998-12-31 | $5.70 Million | $-4.20 Million | -0.737x | -- |
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more